TRANSMID

Welcome to the Brand page for “TRANSMID”, which is offered here for In the statement, column 2, line 9, 4-7-2003 should be deleted, and, 7-4-2003 should be inserted.;pharmaceutical and biochemical preparations for treatment of cancer, brain tumors and in the field of oncology; protein conjugates and receptor targeted conjugates for use in oncology;instruments and apparatus for the administration of pharmaceuticals for the treatment of cancer and brain tumors, syringes and dispensing devices;licensing of intellectual property; biotechnology services, pharmaceutical and bioceutical research and development services;.

Its status is currently believed to be active. Its class is unavailable. “TRANSMID” is believed to be currently owned by “XENOVA LIMITED”.


Owner:
XENOVA LIMITED
Owner Details
Description:
In the statement, Column 2, line 9, 4-7-2003 should be deleted, and, 7-4-2003 should be inserted.;pharmaceutical and biochemical preparations for treatment of cancer, brain tumors and in the field of oncology; protein conjugates and receptor targeted conjugates for use in oncology;instruments and apparatus for the administration of pharmaceuticals for the treatment of cancer and brain tumors, syringes and dispensing devices;licensing of intellectual property; biotechnology services, pharmaceutical and bioceutical research and development services;
Categories: STATEMENT